Using RNA-seq for detecting MRD in multiple myeloma: high sensitivity and prognostic value.
Saved in:
| Title: | Using RNA-seq for detecting MRD in multiple myeloma: high sensitivity and prognostic value. |
|---|---|
| Authors: | Ren Y; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Liu M; Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, Heilongjiang Province, China., Fang J; Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, Heilongjiang Province, China., Wang L; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Xue Y; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Zhao W; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Liu J; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Yu L; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Jin Y; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Chen L; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Tian Y; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Gao X; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Zhang X; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Han B; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Yao D; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Song Y; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Chen X; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Wang F; Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, Heilongjiang Province, China., Ma X; Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, Heilongjiang Province, China., Liu H; Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, Heilongjiang Province, China. starliu@pku.edu.cn.; Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China. starliu@pku.edu.cn.; Division of Pathology and Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China. starliu@pku.edu.cn.; Department of Oncology, Capital Medical University, Beijing, China. starliu@pku.edu.cn., Wang W; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China. weiwang0_0@163.com. |
| Source: | Cancer gene therapy [Cancer Gene Ther] 2026 Jan; Vol. 33 (1), pp. 65-75. Date of Electronic Publication: 2025 Oct 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5500 (Electronic) Linking ISSN: 09291903 NLM ISO Abbreviation: Cancer Gene Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
